Skip to content

Homeopathic treatment of pimples

Efficacy of Individualized Homoeopathic Medicines in Treatment of Acne Vulgaris: Double Blind, Randomized, Placebo Controlled, Clinical Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/11/016248
Enrollment
126
Registered
2018-11-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Individualised homeopathic medicines in centesimal potencies: Intervention is planned as administering indicated homoeopathic medicines in centesimal potencies, as decided appropriate t
dosage and repetition depending upon the individual requirement of the cases. This arm will also receive standardized LSM guidelines. Duration of therapy: 12 weeks.

Sponsors

National Institute Of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from acne vulgaris 2. Both sexes 3. Age between 12 and 30 years 4. Patients giving written consent to participate 5. Literate patients who can read English and/or Bengali

Exclusion criteria

Exclusion criteria: 1. Patients having severe form of acne vulgaris 2. Patients using oil based cosmetics for long period of time 3. Patients who are too sick for consultation 4. Unwilling to take part and not giving consent to join the study 5. Unable to read patient information sheet 6. Diagnosed cases of unstable mental or psychiatric illness 7. Uncontrolled or life threatening illness affecting quality of life or any organ failure 8. Pregnancy and lactation 9. Substance abuse and/or dependence 10. Self-reported immune compromised state 11. Undergoing homoeopathic treatment for any chronic disease within last 6 months

Design outcomes

Primary

MeasureTime frame
Global Acne Grading System (GAGS) scoreTimepoint: At baseline and after 12 weeks

Secondary

MeasureTime frame
Cardiff Acne Disability Index (CADI)Timepoint: At baseline and after 12 weeks;Dermatology Life Quality Index (DLQI)Timepoint: At baseline and after 12 weeks

Countries

India

Contacts

Public ContactGobind Narayan Gupta

National Institute of Homoeopathy

dr.gn05gupta@gmail.com9163197805

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 12, 2026